Biologics CDMO Europe 2025
Bioconjugation Insights · 2025
DOI: 10.18609/bci.2025.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugation Insights, 2025. Verfasst von No Author Supplied. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
As part of our ongoing coverage of key gatherings in life sciences, BioInsights presents a preview of Biologics CDMO Europe 2025. Scheduled for November 19–20, 2025, in Munich, Germany, this summit will unite up to 300 senior manufacturing and external supply-chain experts from across Europe. Focusing on agile, tech-enabled biologics manufacturing, regulatory alignment, and strategic CDMO partnerships, the agenda features off-the-record case studies, executive roundtables, and deep-dive sessions.
Zitieren
APA
Supplied, N. A. (2025). Biologics CDMO Europe 2025. Bioconjugation Insights. https://doi.org/10.18609/bci.2025.019
Vancouver
Supplied NA. Biologics CDMO Europe 2025. Bioconjugation Insights. 2025. doi:10.18609/bci.2025.019
BibTeX
@article{Supplied2025,
author = {Supplied, No Author},
title = {Biologics CDMO Europe 2025},
journal = {Bioconjugation Insights},
year = {2025},
doi = {10.18609/bci.2025.019}
}
EUVIMED